2011•Annals of OncologyOpen access

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

Giovanni Francesco D'Arena, Caterina Giovanna Valentini, Giuseppe Pietrantuono, Roberto Guariglia, M.C. Martorelli, Giovanna Mansueto, Oreste Villani, Daniela Onofrillo, Antonietta Pia Falcone, Giorgina Specchia, Gianpietro Semenzato, Nicola Di Renzo, Lucia Mastrullo, Adriano Venditti, Ferdinando Ferrara, Antonio Palumbo, Livio Pagano, Pellegrino Musto

Open full text 83 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 83 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Bortezomib, Multiple myeloma, Plasma cell leukemia, Internal medicine, Melphalan, Vincristine, Thalidomide

Related papers

Back to paper searchBrowse research topicsOriginal source
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party — Research Paper | ScholarLens